MiMedx Group, Inc. (MDXG)

MiMedx Group Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	321.48	267.84	242.02	248.23	299.26
Revenue Growth (YoY)	20.03%	10.67%	-2.50%	-17.05%	-16.67%
Cost of Revenue	54.63	48.32	39.63	39.33	43.08
Gross Profit	266.84	219.53	202.39	208.9	256.17
Selling, General & Admin	211.12	208.67	194.85	181.02	198.21
Research & Development	12.67	12.7	9.93	11.72	11.14
Other Operating Expenses	5.96	12.88	4.69	61.57	67.99
Operating Expenses	229.75	234.26	209.47	254.31	277.33
Operating Income	37.09	-14.73	-7.07	-45.4	-21.16
Interest Expense / Income	6.46	5.02	4.98	7.94	4.71
Other Expense / Income	9.21	10.24	-2.02	42.25	-0.28
Pretax Income	21.42	-29.99	-10.04	-95.59	-25.59
Income Tax	-36.81	0.21	0.25	-12.26	-0.01
Net Income	58.23	-30.2	-10.29	-83.33	-25.58
Shares Outstanding (Basic)	116	113	110	108	107
Shares Outstanding (Diluted)	146	113	110	108	107
Shares Change	29.27%	2.32%	1.94%	1.23%	1.28%
EPS (Basic)	0.40	-0.33	-0.15	-0.77	-0.24
EPS (Diluted)	0.37	-0.33	-0.15	-0.77	-0.24
Free Cash Flow	24.79	-19.38	-5.2	-34.49	-41.16
Free Cash Flow Per Share	0.21	-0.17	-0.05	-0.32	-0.39
Gross Margin	83.01%	81.96%	83.63%	84.16%	85.60%
Operating Margin	11.54%	-5.50%	-2.92%	-18.29%	-7.07%
Profit Margin	18.11%	-11.27%	-4.25%	-33.57%	-8.55%
Free Cash Flow Margin	7.71%	-7.24%	-2.15%	-13.89%	-13.76%
Effective Tax Rate	-171.81%	-	-	-	-
EBITDA	32.57	-19.67	1.11	-79.81	-12.35
EBITDA Margin	10.13%	-7.34%	0.46%	-32.15%	-4.13%
Depreciation & Amortization	4.7	5.31	6.17	7.84	8.53
EBIT	27.88	-24.98	-5.06	-87.65	-20.88
EBIT Margin	8.67%	-9.32%	-2.09%	-35.31%	-6.98%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).